Tissue Specificity | P31725 - NAP06702 - Calprotectin (S100A8/9) is predominantly expressed in myeloid cells. Except for inflammatory conditions, the expression is restricted to a specific stage of myeloid differentiation since both proteins are expressed in circulating neutrophils and monocytes but are absent in normal tissue macrophages and lymphocytes. Under chronic inflammatory conditions, such as psoriasis and malignant disorders, also expressed in the epidermis. Found in high concentrations at local sites of inflammation or in the serum of patients with inflammatory diseases such as rheumatoid, cystic fibrosis, inflammatory bowel disease, Crohn's disease, giant cell arteritis, cystic fibrosis, Sjogren's syndrome, systemic lupus erythematosus, and progressive systemic sclerosis. Involved in the formation and deposition of amyloids in the aging prostate known as corpora amylacea inclusions. Strongly up-regulated in many tumors, including gastric, esophageal, colon, pancreatic, bladder, ovarian, thyroid, breast and skin cancers. |
Alternative Antibody Names | Anti-Protein S100-A9 antibodyAnti-Calgranulin-B antibodyAnti-Leukocyte L1 Complex Heavy Chain antibodyAnti-Migration Inhibitory Factor-Related Protein 14 antibodyAnti-Mrp-14 antibodyAnti-P14 antibodyAnti-S100 Calcium-Binding Protein A9 antibodyAnti-S100a9 antibodyAnti-Cagb antibodyAnti-Mrp14 antibodyAnti-Protein S100-A9 antibodyAnti-Calgranulin-B antibodyAnti-Calprotectin L1h Subunit antibodyAnti-Leukocyte L1 Complex Heavy Chain antibodyAnti-Migration Inhibitory Factor-Related Protein 14 antibodyAnti-Mrp-14 antibodyAnti-P14 antibodyAnti-S100 Calcium-Binding Protein A9 antibodyAnti-S100A9 antibodyAnti-CAGB antibodyAnti-CFAG antibodyAnti-MRP14 antibody |
Information sourced from Uniprot.org